The relationship of circulating insulin-like growth factor 1, its binding protein-3, prostate-specific antigen and C-reactive protein with disease stage in prostate cancer
Open Access
- 28 February 2002
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 89 (4), 396-399
- https://doi.org/10.1046/j.1464-4096.2001.01641.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Serum insulin‐like growth factor‐1 is not a useful marker of prostate cancerBJU International, 1999
- Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) in immunity and inflammationCytokine & Growth Factor Reviews, 1999
- Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study.JNCI Journal of the National Cancer Institute, 1998
- Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective StudyScience, 1998
- Insulin-like Growth Factors in Health and DiseaseAnnals of Internal Medicine, 1992
- Serum Tumour Markers in Human Prostatic Carcinoma: The value of a marker panel for prognostic informationActa Oncologica, 1991
- Editorial: The Possible Autocrine/Paracrine and Endocrine Roles of Insulin-Like Growth Factors of Human TumorsEndocrinology, 1990
- Insulin-Like Growth Factors I and II. Peptide, Messenger Ribonucleic Acid and Gene Structures, Serum, and Tissue Concentrations*Endocrine Reviews, 1989
- An Evaluation of Serum Protein Profiles in the Long-Term Surveillance of Prostatic CancerScandinavian Journal of Urology and Nephrology, 1980
- Acute Phase Reactant Proteins in Prostatic CancerBritish Journal of Urology, 1977